Internet Archive Scholar

SP544EFFECTS OF NEBIVOLOL AND IRBESARTAN ON AMBULATORY BLOOD PRESSURE IN HEMODIALYSIS PATIENTS WITH INTRADIALYTIC HYPERTENSION: PRELIMINARY RESULTS FROM A RANDOMIZED CROSS-OVER STUDY

Athanasios Bikos, Loutradis Charalampos, Antonios Karpetas, Vasilios Raptis, Alexia Piperidou, Rigas Kalaitzidis, Evdoxia Ginikopoulou, Stylianos Panagoutsos, Ploumis Pasadakis, Ilias Balaskas, Aikaterini Papagianni, Vasilios Liakopoulos (+1 others)
2017 Nephrology, Dialysis and Transplantation  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (73.1 kB)
https://web.archive.org/web/20190503135746/https://watermark.silverchair.com/gfx152.sp544.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAlIwggJOBgkqhkiG9w0BBwagggI_MIICOwIBADCCAjQGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQM-ts-B4moqVTDVGteAgEQgIICBbNai6okcFN4lVnmwH_BI_hd07G0Zg8ULafgvid08s6c_wWXQ3VpqSlFJy9wj04f-FLacbWJD9lLNVNuZZ3erzKS9SrsxKTlJrqp-gEZ4dK7Sv4SuWdTmjGu-oQuCXbIR9Okp3FDwAihJ4eD748LKlb2j5Ag7WJX_zEMjmhwO6ahIrlNDe8IUgjzZ3-azK-r0SXeGanrDIRMrq7eP70pRtr5ifd55_-7f7iKo5hitxeOXTZoE6Gy2Ec90Ip8c-hOsVKLe1hm2bR4ggicFZtRz-UVTuLwjJCWX8BZRFo-MyXPoXDEXX3cAuWNzoeQ6LJ435WXFCbcM84NWVY5oOQRUiiWh-m7dAoBzeZjTKLi7OTPUvQcIbgSlvBAzgkX_7SudOpl5ykaAM_J6syPh0su4dF2udOc9y4BiHYbgmzMNkLz3zNLU64eCUxsrjOUnuwhJpBmQXYIIn_D71hyTE1uaApZtmvmsyF-UgtE0L0ysbUA8g-nNE4jY7zxoOeTMgnqNFS2UID4pjUZW33BUk-Nh6qukOA1m1NlP257k6AAZg6tc07ae9858Dt7MXRXpgqq2sNgguqlS9znq7t0EegG2n5kznsaYfXoFZek995DQx5pfwRgpDNbHy0S3zEpkv_oYiIN7zRbavauYAQxLlLi5nfbH2zUuoojeXMFMzWLjGHzqiaF2Pg

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL. The file type is application/pdf.

INHD= -14.75g [CI: -29.62-0.12], CHD= 6.54 g [CI: -7.48-20.57], P=0.02), with a significant improvement in LV mass/LV end-diastolic volume in the INHD group compared to CD group (mean difference; INHD= -0.07g/ml [CI: -0.15-0], CHD= 0.06g/ml [CI: -0.01-0.13], P=0.01), and no change in LV end-diastolic volume. There was a significant reduction in global native T1 in the INHD group compared to the CD group (mean difference; INHD= -30.62ms [95% CI: -56.49, 4.75], CHD=0.4ms [95% CI: -25.47, 26.27],
more » ... =0.05) and non-septal native T1 values (mean difference; INHD= -30.93ms [95% CI: -58.44, -3.41], CHD=8.96ms [95% CI: -18.56, 36.47], P=0.02). There were non-significant improvements in ejection fraction, GLS, GCS and aPWV in the INHD group compared to the CD group. Reduction in LV Mass correlated significantly with reduction in native T1 ((r=0.526, P=0.03). CONCLUSIONS: A six-month program of extended hours INHD was associated with a reduction in LV mass and favourable LV remodelling. The reduction in native T1 mapping in INHD patients suggest a reduction in myocardial fibrosis compared to control patients who remained on thrice weekly, 4-hour HD. These data merit testing in future larger trials of INHD.
doi:10.1093/ndt/gfx152.sp544 fatcat:3iqcdnf365afnlpgtpznpk6ona
Citation

Athanasios Bikos, Loutradis Charalampos, Antonios Karpetas, Vasilios Raptis, Alexia Piperidou, Rigas Kalaitzidis, Evdoxia Ginikopoulou, Stylianos Panagoutsos, Ploumis Pasadakis, Ilias Balaskas, Aikaterini Papagianni, Vasilios Liakopoulos, Pantelis Sarafidis. "SP544EFFECTS OF NEBIVOLOL AND IRBESARTAN ON AMBULATORY BLOOD PRESSURE IN HEMODIALYSIS PATIENTS WITH INTRADIALYTIC HYPERTENSION: PRELIMINARY RESULTS FROM A RANDOMIZED CROSS-OVER STUDY." Nephrology, Dialysis and Transplantation 32.suppl_3 (2017) iii314-iii315